![A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should. - ppt download A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should. - ppt download](https://images.slideplayer.com/14/4405639/slides/slide_3.jpg)
A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should. - ppt download
![Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram](https://www.researchgate.net/publication/314651177/figure/tbl1/AS:669016997756939@1536517490370/Individual-immune-responses-to-a-challenge-dose-of-hepatitis-A-or-and-hepatitis-B-vaccine_Q320.jpg)
Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram
![One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review - ScienceDirect One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X21000542-gr3.jpg)
One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review - ScienceDirect
![Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/91dbf75b-2288-4086-9df9-adddee7ae55e/gr1_lrg.jpg)
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial - The Lancet Infectious Diseases
![Vaccinology : Hepatitis A Vaccine : Hepatitis A Vaccine Introduction : Diseases and Conditions | Pediatric Oncall Vaccinology : Hepatitis A Vaccine : Hepatitis A Vaccine Introduction : Diseases and Conditions | Pediatric Oncall](https://www.pediatriconcall.com/master/bucket-img/174-hepatitis-a-vaccine/hepatitis-a-vaccine-1.jpg)
Vaccinology : Hepatitis A Vaccine : Hepatitis A Vaccine Introduction : Diseases and Conditions | Pediatric Oncall
![SciELO - Saúde Pública - Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted SciELO - Saúde Pública - Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted](https://www.scielosp.org/media/assets/rpsp/v21n6/02t5.gif)